Patents by Inventor Robert Fleming

Robert Fleming has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Satellite communications system utilizing parallel concatenated coding
    Patent number: 5734962
    Abstract: A VSAT satellite communications network utilizes parallel concatenated coding on its inbound or outbound links, or both. For short data blocks, nonrecursive systematic tail-biting convolutional codes are used. For longer data blocks, recursive systematic convolutional codes are used. These parallel concatenated coding techniques are used in conjunction with spread-spectrum modulation to provide a VSAT communications system which meets FCC regulations on the total power spectral density of transmitted signals as well as mitigates interference from adjacent satellites.
    Type: Grant
    Filed: July 17, 1996
    Date of Patent: March 31, 1998
    Assignee: General Electric Company
    Inventors: Stephen Michael Hladik, William Alan Check, Brian James Glinsman, Robert Fleming Fleming, III
  • N-(2,6-disubstituted aromatic)-N'-pyridinyl ureas
    Patent number: 4962116
    Abstract: N-(2,6-Disubstitutedphenyl)-N'-3- and 4-pyridinyl ureas and pharmaceutically acceptable acid addition salts having anticonvulsant activity are described as well as a process for their manufacture, formulations containing the compounds and a method of treating epilepsy using the compounds in unit dosage form.
    Type: Grant
    Filed: March 19, 1986
    Date of Patent: October 9, 1990
    Assignee: Warner-Lambert Company
    Inventors: Sandra J. Lobbestael, Ivan C. Nordin, Robert Fleming
  • Anticonvulsant N-(2,6-disubstituted aromatic)-n'-pyridinyl ureas
    Patent number: 4629731
    Abstract: N-(2,6-Disubstitutedphenyl)-N'-3- and 4-pyridinyl ureas and pharmaceutically acceptable acid addition salts having anticonvulsant activity are described as well as a process for their manufacture, formulations containing the compounds and a method of treating epilepsy using the compounds in unit dosage form.
    Type: Grant
    Filed: April 30, 1985
    Date of Patent: December 16, 1986
    Assignee: Warner-Lambert Company
    Inventors: Sandra J. Lobbestael, Ivan C. Nordin, Robert Fleming